NCT01182415View on ClinicalTrials.gov

High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Non-Hodgkin's LymphomaCNS Lymphoma
Interventions
PROCEDURE

Autologous stem cell transplant

Autologous stem cell transplant following high-dose chemotherapy

DRUG

High-dose chemotherapy

High-dose chemotherapy with rituximab, thiotepa, busulfan, and cyclosphosphamide

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Otsuka America Pharmaceutical

INDUSTRY

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Massachusetts General Hospital

OTHER